BioHarvest Sciences Inc (NAS:BHST)

Q3 2025 Bioharvest Sciences Inc Earnings Call Transcript

Nov 13, 2025 / 09:30 PM GMT

Release Date Price: $7.3 (-7.59%)

Transcript

Key Points

Positve

BioHarvest Sciences Inc (BHST) reported a 39% year-over-year increase in total revenues, reaching $9.1 million for Q3 2025, aligning with their guidance.
The company's core vineyard capsules business accounted for 88% of product revenues, with new products contributing 12%, indicating a healthy product diversification.
The CDMO business showed significant growth, with revenues increasing by 722% to $0.7 million, highlighting the potential of this business segment.
Gross profit margins improved to 61%, benefiting from increased manufacturing scale and improved yields.
BioHarvest Sciences Inc (BHST) successfully raised $19.9 million through institutional equity financing, strengthening their balance sheet and funding future growth initiatives.

Negative

Despite revenue growth, BioHarvest Sciences Inc (BHST) reported a net loss of $2.5 million for Q3 2025, slightly lower than the $2.7 million loss in the same quarter last year.
Operating expenses increased to $6.5 million, driven by higher marketing spend and development costs for the health affiliate program.
The company is still working towards achieving adjusted EBITDA breakeven, with expectations to reach this milestone in early 2026.
The competitive nature of the $17 billion US electrolyte hydration market poses challenges for the new vineo blood flow hydration product.
The CDMO business, while growing, still represents a smaller portion of total revenues compared to the direct-to-consumer products.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

8MV0.MU - Bioharvest Sciences Inc
Q3 2025 Bioharvest Sciences Inc Earnings Call
Nov 13, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Bioharvest Sciences 3rd quarter 2025 corporate update conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we begin the formal presentation, I'd like to remind everyone that statements made on today's call and webcast, including those regarding future financial results and industry prospects, are forward-looking and may be subject to a number of risks and uncertainties.

That could cause actual results to differ materially from those described on the call, please refer to the company's regulatory filings for a list of associated risks, and we would

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.